Hepatic SNHG9 links gut microbiota to liver protection in drug-induced liver injury
Authors:
Open Access
- 20 May 2026
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Drug-induced liver injury (DILI) is a leading cause of acute liver failure, posing a significant public health burden. Emerging evidence underscores the gut microbiota as a critical environmental factor that profoundly influences liver function and DILI progression, yet the underlying mechanisms remain poorly understood. Here, we identify hepatic long non-coding RNA SNHG9 as a key mediator linking the gut microbiota to acetaminophen (APAP)-induced liver injury. Upregulation of hepatic SNHG9 protects against hepatotoxicity by activating MAS, a G protein-coupled receptor that facilitates the clearance of cellular damage via enhanced autophagy. Mechanistically, SNHG9 binds to insulin-like growth factor 2 mRNA-binding protein 2 (IMP2), enhancing its interaction with MYC mRNA and suppressing MYC translation. Since MYC acts as a transcriptional repressor of the MAS1 gene, this suppression leads to upregulated MAS expression. Notably, hepatic SNHG9 expression is modulated by the gut microbiota, particularly through the metabolite 2-hydroxy 2-methylbutyric acid (HMB). Supplementation with HMB or HMB-producing microbes robustly induces hepatic SNHG9 expression and attenuates APAP-induced liver injury. Our findings unveil a previously unrecognized gut-liver axis and provide mechanistic insight into how gut microbiota regulate hepatic stress responses, suggesting potential avenues for modulating this pathway in drug-induced liver injury.Keywords
Funding Information
- National Natural Science Foundation of China (32271213; 32471189; 82188102)
- National Natural Science Foundation of China (82302899)
- Department of Science and Technology for Social Development (2021YFA0805600)
- Natural Science Foundation of Zhejiang Province (R26C110002)
- Natural Science Foundation of Zhejiang Province (LQ24H160004)
- Science and Technology Department of Zhejiang Province (2025C02128)
This publication has 38 references indexed in Scilit:
- Gut microbiota protect against colorectal tumorigenesis through lncRNA Snhg9Developmental Cell, 2025
- Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive OverviewCellular and Molecular Gastroenterology and Hepatology, 2024
- MYC as a target for cancer treatmentCancer Treatment Reviews, 2021
- Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver InjuryCell Metabolism, 2020
- Pre-treatment with angiotensin-(1–7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenograftsJournal of Molecular Medicine, 2018
- Beta‐hydroxy‐beta‐methylbutyrate supplementation and skeletal muscle in healthy and muscle‐wasting conditionsJournal of Cachexia, Sarcopenia and Muscle, 2017
- Functional role of CCL5/RANTES for HCC progression during chronic liver diseaseJournal of Hepatology, 2017
- Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in miceJournal of Hepatology, 2016
- Drug-induced Acute Liver FailureClinics in Liver Disease, 2013
- Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIPCell, 2010